Host Acid Sphingomyelinase Regulates Microvascular Function Not Tumor Immunity
Open Access
- 15 November 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 64 (22), 8285-8291
- https://doi.org/10.1158/0008-5472.can-04-2715
Abstract
Previous studies provided evidence that MCA/129 fibrosarcomas and B16 melanomas grow 2- to 4-fold faster in acid sphingomyelinase (asmase)–deficient mice than in asmase+/+ littermates and are resistant to single-dose irradiation due to inability to mount an apoptotic response in tumor microvascular endothelium. However, others postulated the differences might be associated with a host antitumor immune response in asmase+/+ mice that is not expressed in asmase−/− mice due to phenotypic deficiency in antitumor immunity. The present studies demonstrate that none of the tumor–host combinations displayed the classic criteria of an immunogenic tumor because they lacked endotumoral or peritumoral infiltrates almost entirely. Furthermore, neither MCA/129 fibrosarcoma nor B16 melanoma tumors showed differences in growth or radioresponsiveness when implanted into mutant mouse models (Rag−/− and MEF−/−) lacking functional immune cell [natural killer (NK), NK-T, T, and B cells] populations. Additionally, development and function of B-, T-, and NK-cell populations in asmase−/− mice were normal, indistinguishable from their wild-type littermates. These data provide definitive evidence that MCA/129 fibrosarcomas and B16F1 melanomas do not elicit a host immune response in wild-type mice and that the asmase−/− phenotype is not deficient in antitumor immunity, supporting the notion that the patterns of tumors growth and radiation response are conditionally linked to the ability of the tumor endothelium to undergo ASMase-mediated apoptosis.Keywords
This publication has 41 references indexed in Scilit:
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004
- Comment on "Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis" (II)Science, 2003
- Comment on "Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis" (I)Science, 2003
- The Activation of c-Jun NH2-terminal Kinase (JNK) by DNA-damaging Agents Serves to Promote Drug Resistance via Activating Transcription Factor 2 (ATF2)-dependent Enhanced DNA RepairJournal of Biological Chemistry, 2003
- Tumor Response to Radiotherapy Regulated by Endothelial Cell ApoptosisScience, 2003
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in MiceScience, 2001
- ACID SPHINGOMYELINASE-DERIVED CERAMIDE IS NOT REQUIRED FOR INFLAMMATORY CYTOKINE SIGNALLING IN MURINE MACROPHAGESCytokine, 1998
- RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangementCell, 1992
- Immunologic status of host and response of a methylcholanthrene-induced sarcoma to local x-irradiationCancer, 1970